| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |